Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model

Clinical trial NCT06880419 · RECRUITING

Trial details

NCT number: NCT06880419
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Graft-versus-Host Disease

Start date: 2025-03-03
Primary completion: 2025-12-31
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.